Chilton Capital Management LLC Astrazeneca PLC Transaction History
Chilton Capital Management LLC
- $2.32 Billion
- Q4 2024
A detailed history of Chilton Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Chilton Capital Management LLC holds 362,445 shares of AZN stock, worth $26.9 Million. This represents 1.03% of its overall portfolio holdings.
Number of Shares
362,445
Previous 349,556
3.69%
Holding current value
$26.9 Million
Previous $27.2 Million
12.81%
% of portfolio
1.03%
Previous 1.16%
Shares
27 transactions
Others Institutions Holding AZN
# of Institutions
1,356Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.48 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.04 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.78 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.75 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.78 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...